DRIO: יחס P/E מותאם צמיחה DarioHealth Inc

The historical PEG ratio demonstrates the resilience of DarioHealth Corp. (DRIO), with 0.00 reflecting the metric's most recent value. Digital therapeutics here replace physician visits with automated AI monitoring. The integration of smart glucometers ensures the loyalty of patients with chronic pathologies, although fierce competition in the B2B segment is forcing the company to lower the cost of corporate subscriptions.

DarioHealth Corp. (DRIO) SaaS subscriptions for chronic disease management generate a stable cash flow through B2B contracts. Analyzing the fair value level via the PEG ratio, an investor sees the current value of 0.00. This metric compares the P/E ratio with earnings growth rates, determining the cost per unit of business expansion. A value below one confirms the asset is undervalued relative to its growth dynamics, making the company a promising candidate for long-term growth.